All these findings contribute to explaining the crucial role of stromal Cav1 as a regulator of cytokine production and inflammation [18] and their harmful consequences on the poor clinical outcome observed in patients with decreased Cav1 expression in breast [18,22], ovarian [23,28] and lung cancer [29]. Here, CAV1 is linked to lung cancer.